MAY 22, 2018 12:00 PM PDT

Breakthrough Analysis Outlines Conceivable Cause of Childhood ALL

WRITTEN BY: Mauri Brueggeman

A British cancer biologist and Professor of Cell Biology at the Institute of Cancer Research (ICR) in London, Dr. Mel Greaves, published a comprehensive literature review in Nature Reviews Cancer yesterday as an update to his search for the causal mechanisms of most Acute Lymphoblastic Leukemia (ALL) diagnoses.  Some are calling it the most comprehensive review of ALL ever published.  It brings together and evaluates research and clinical findings of the disease over the past 35+ years with some leukemia studies coming from the early 20th century.  In the 1990’s, Dr. Greaves and his ICR team discovered mutations present in identical twins before birth; these mutations were determined to contribute to leukemia development sometime after birth.  His work has since focused on what causes the development of ALL in children, specifically in those young people ages 2 to 5 years of age. 

His published theory is that along with those initial in-utero mutations, children acquire a second mutation as a result of delayed childhood infection from an abnormal immune response.  He has gathered, analyzed, and shared significant evidence to support his theory.  He believes that the data suggests that children who are exposed to infections as babies develop a normal immune response and that gives them some protection against leukemia.  There are some important pieces to keep in mind, however.  Like other cancers, the risk of childhood leukemia development is as of yet, undetermined.  How that first hit develops and the cause is not well understood.

The initial findings in-utero utilized research focused on sets of twins who both developed ALL between those specified age ranges of 2-5 years old.  Current technological advances in molecular modeling and sequencing have allowed better opportunities to characterize some of these findings.  The initial mutation in-utero is found to be identical in both twins.  Dr. Greaves writes that this finding is due to a mutation that arises in one twin and a population of pre-cancerous cells form.  Because the blood supply is shared between the twins, these pre-cancerous cells travel to the other twin and produce another pre-cancerous population in that environment, similar to the metastatic process. 

The delayed infection theory is not new.  Many believe that there is significant positive impact to an individual’s immune system with exposure to an early childhood infection.  No one is suggesting that a serious illness is necessary; however, the early infection is believed to help set up a baby’s immune response ability as compared to children who are kept in “cleaner” environments away from other children and away from potential risks for infection.  There are connections being made between an “under prepped” or “unprimed” immune system early in life and development of autoimmune diseases, allergies, and type 1 diabetes. 

The second mutation, or second “hit” as some call it, comes postnatally.  In the study of the twins with ALL, the first mutation is identical but the second is different between the two twins.  This leads researchers to the theory that it is caused by some later event, exposure, or unique change within the individual.  Studies evaluating this theory and the potential infectious agents that could be the cause do not suggest there is one single virus or bacteria to blame.  The data points to a multitude of common viruses and bacteria that can trigger the infection which comes after an immune system “priming” window when the children are babies. 

Another data point is that ALL appears to be a disease of affluent society’s children.  These are children that have parents of means; that means is used to protect babies from exposure to risks and environmental elements like common microbes or viruses.  Dr. Greaves did not find significant linkages to previously identified environmental causative theories like ionizing radiation or chemical exposure.  Not to say these are not possible additive factors in developing those “hits” to the pre-cancerous cells.  There are additional factors including inherited mutations, genetic disorders, and others that can predispose children to development of ALL outside of the discussion regarding delayed infection.

Another data set came from murine studies that created mice with a mutated leukemia initiating gene which were then placed in an ultra-clean environment at birth.  They lived in that environment and were subsequently moved to an environment with common microbes.  The mice developed ALL. 

There is still much to be done to fully understand the mechanisms that cause development of ALL but these findings are important to consider; can we, as a society that worries about our kids getting sick with minor inconvenient illnesses, be a little less protective to allow their immune systems to get ready fight the bigger fights later on in life? 

Sources: Institute of Cancer Researchhttps://www.icr.ac.uk; Nature Reviews Cancer; ICR Researchers/Teams; Haematologica; Blood Cells, Molecules, and Diseases; Environmental Health Perspective; American Journal of Epidemiology;

 

 

About the Author
  • Mauri S. Brueggeman is a Medical Laboratory Scientist and Educator with a background in Cytogenetics and a Masters in Education from the University of Minnesota. She has worked in the clinical laboratory, taught at the University of Minnesota, and been in post secondary healthcare education administration. She is passionate about advances and leadership in science, medicine, and education.
You May Also Like
MAR 13, 2020
Cancer
MAR 13, 2020
To lower HPV infections, vaccinate boys, too
Past studies and a strategy put forth by the WHO have predicted that it is possible to eradicate cervical cancer within ...
MAR 23, 2020
Genetics & Genomics
MAR 23, 2020
Diagnosing Cancer by Looking for Microbial DNA in the Blood
Liquid biopsies aim to diagnose a disease with only a bit of biological fluid, usually blood.
MAR 29, 2020
Cancer
MAR 29, 2020
MicroRNA as a New Way to Test for Lung Cancer
The most common, and most deadly, cancer across the world is lung cancer. If caught early, lung cancer has quite a low m ...
APR 06, 2020
Immunology
APR 06, 2020
Clearing the Path for Dendritic Cells to Eliminate Tumors
  Dendritic cells are the sentinels of the immune system and use their “tree-like” projections to prese ...
APR 23, 2020
Cancer
APR 23, 2020
Dual Inhibition from One Chemotherapy
Acute Myeloid Leukemia, or AML, is an aggressive blood cancer with a poor 5-year prognosis. The primary targets of chemo ...
MAY 21, 2020
Cancer
MAY 21, 2020
A New Player in the Regulation of Cancer's Microenvironment
Breast cancer is one of the most common cancers in the world.  Triple-negative breast cancer (TNBC) is a sub-type o ...
Loading Comments...